Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma

Articles in the same Issue

1. Allergy testing: the role of recombinant allergens
2. Autoimmune diagnostics in diabetes mellitus
3. Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
4. Autoimmune bullous disorders
5. Laboratory network of excellence: enhancing patient safety and service effectiveness
6. Novel mutations in the 5′-UTR of the FOLR1 gene
7. CYP2C8 polymorphism among the Portuguese
8. Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
9. Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
10. Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
11. Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
12. Total tau protein, phosphorylated tau (181p) protein, β-amyloid_1–42, and β-amyloid_1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
13. Establishment of an indocyanine green test using an automatic chemistry analyzer
14. Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
15. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
16. Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
17. Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
18. Measurement of glycated hemoglobin (HbA_1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
19. Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
20. Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
21. Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
22. Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary